Effects of anaesthetics and lazaroid U-83836E on survival of transplanted rat dopaminergic neurones. 1999

J Karlsson, and R M Love, and D J Clarke, and P Brundin
Section for Neuronal Survival, Wallenberg Neuroscience Center, Department of Physiology and Neuroscience, University of Lund, Sölvegatan 17, S-223 62, Lund, Sweden. jenny.karlsson@mphy.lu.se

We investigated whether different methods of anaesthesia, used on the pregnant rat when collecting embryonic donor tissue, and a lipid peroxidation inhibitor (lazaroid U-83836E) affect the survival of grafted embryonic dopaminergic neurones in hemiparkinsonian rats. There was no difference in either functional recovery or survival of dopaminergic neurones between the different euthanasia groups: (a) isoflurane sedation followed by cervical dislocation, (b) equithesin- or (c) euthatal-anaesthesia. However, lazaroid-treatment enhanced both behavioural recovery and transplant survival.

UI MeSH Term Description Entries
D007530 Isoflurane A stable, non-explosive inhalation anesthetic, relatively free from significant side effects.
D008278 Magnesium Sulfate A small colorless crystal used as an anticonvulsant, a cathartic, and an electrolyte replenisher in the treatment of pre-eclampsia and eclampsia. It causes direct inhibition of action potentials in myometrial muscle cells. Excitation and contraction are uncoupled, which decreases the frequency and force of contractions. (From AMA Drug Evaluations Annual, 1992, p1083) Magnesium Sulfate, Heptahydrate,Heptahydrate Magnesium Sulfate,Sulfate, Magnesium
D009474 Neurons The basic cellular units of nervous tissue. Each neuron consists of a body, an axon, and dendrites. Their purpose is to receive, conduct, and transmit impulses in the NERVOUS SYSTEM. Nerve Cells,Cell, Nerve,Cells, Nerve,Nerve Cell,Neuron
D010302 Parkinson Disease, Secondary Conditions which feature clinical manifestations resembling primary Parkinson disease that are caused by a known or suspected condition. Examples include parkinsonism caused by vascular injury, drugs, trauma, toxin exposure, neoplasms, infections and degenerative or hereditary conditions. Clinical features may include bradykinesia, rigidity, parkinsonian gait, and masked facies. In general, tremor is less prominent in secondary parkinsonism than in the primary form. (From Joynt, Clinical Neurology, 1998, Ch38, pp39-42) Atherosclerotic Parkinsonism,Secondary Parkinsonism,Symptomatic Parkinson Disease,Parkinson Disease, Secondary Vascular,Parkinson Disease, Symptomatic,Parkinsonism, Secondary,Parkinsonism, Symptomatic,Secondary Vascular Parkinson Disease,Parkinsonism, Atherosclerotic,Secondary Parkinson Disease,Symptomatic Parkinsonism
D010424 Pentobarbital A short-acting barbiturate that is effective as a sedative and hypnotic (but not as an anti-anxiety) agent and is usually given orally. It is prescribed more frequently for sleep induction than for sedation but, like similar agents, may lose its effectiveness by the second week of continued administration. (From AMA Drug Evaluations Annual, 1994, p236) Mebubarbital,Mebumal,Diabutal,Etaminal,Ethaminal,Nembutal,Pentobarbital Sodium,Pentobarbital, Monosodium Salt,Pentobarbitone,Sagatal,Monosodium Salt Pentobarbital
D010879 Piperazines Compounds that are derived from PIPERAZINE.
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D002470 Cell Survival The span of viability of a cell characterized by the capacity to perform certain functions such as metabolism, growth, reproduction, some form of responsiveness, and adaptability. Cell Viability,Cell Viabilities,Survival, Cell,Viabilities, Cell,Viability, Cell
D002697 Chloral Hydrate A hypnotic and sedative used in the treatment of INSOMNIA. Noctec,Hydrate, Chloral
D002839 Chromans Benzopyrans saturated in the 2 and 3 positions. Dihydrobenzopyrans

Related Publications

J Karlsson, and R M Love, and D J Clarke, and P Brundin
January 2000, Cell transplantation,
J Karlsson, and R M Love, and D J Clarke, and P Brundin
May 1998, Free radical research,
J Karlsson, and R M Love, and D J Clarke, and P Brundin
January 2004, Acta neurobiologiae experimentalis,
J Karlsson, and R M Love, and D J Clarke, and P Brundin
December 1997, Free radical research,
J Karlsson, and R M Love, and D J Clarke, and P Brundin
July 2000, Experimental neurology,
J Karlsson, and R M Love, and D J Clarke, and P Brundin
January 1997, Experimental brain research,
J Karlsson, and R M Love, and D J Clarke, and P Brundin
April 1999, Toxicology and applied pharmacology,
J Karlsson, and R M Love, and D J Clarke, and P Brundin
January 1999, Acta neurobiologiae experimentalis,
J Karlsson, and R M Love, and D J Clarke, and P Brundin
January 2011, Inflammation research : official journal of the European Histamine Research Society ... [et al.],
Copied contents to your clipboard!